The head of Theranos, Elizabeth Holmes issued an open letter on Wednesday, in which she announced that the failing blood testing company will be closing all of its clinical labs and Wellness Centers, including those in Arizona. Holmes expects the closures to impact 340 employees.
The company’s clinical labs and Theranos Wellness Centers’ closures will impact employees in Arizona, California, and Pennsylvania.
Theranos has been under investigation. Its partnership with Walgreens was terminated in June.
The letter reads:
For our stakeholders,
After many months spent assessing our strengths and addressing our weaknesses, we have moved to structure our company around the model best aligned with our core values and mission.
We have decided to close our clinical labs and Theranos Wellness Centers, which will impact approximately 340 employees in Arizona, California, and Pennsylvania. We are profoundly grateful to these team members, many of whom have devoted years to Theranos and our mission, for their commitment to our company and our guests.
We will return our undivided attention to our miniLab platform. Our ultimate goal is to commercialize miniaturized, automated laboratories capable of small-volume sample testing, with an emphasis on vulnerable patient populations, including oncology, pediatrics, and intensive care.
We have a new executive team leading our work toward obtaining FDA clearances, building commercial partnerships, and pursuing publications in scientific journals.
We are fortunate to have supporters and investors who believe deeply in our mission of affordable, less invasive lab testing, and to have the runway to realize our vision.
I look forward to sharing more with you as we progress along the way.
Sincerely,
Elizabeth Holmes